关注
Mehmet Baysal
Mehmet Baysal
Trakya Universtiy
在 trakya.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease
G Yilmaz, C Sevinc, S Ustundag, YC Yavuz, T Hacıbekiroglu, E Hatipoglu, ...
Saudi Journal of Kidney Diseases and Transplantation 28 (1), 90-94, 2017
542017
Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
M Baysal, U Demirci, E Umit, HO Kirkizlar, EI Atli, H Gurkan, SK Gulsaran, ...
Scientific Reports 10 (1), 1-6, 2020
462020
Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy
EG Umıt, M Baysal, V Bas, I Asker, O Kırkızlar, AM Demır
Journal of oncology pharmacy practice 26 (1), 43-50, 2020
272020
Thalidomide for the management of bleeding episodes in patients with hereditary hemorrhagic telangiectasia: effects on epistaxis severity score and quality of life
M Baysal, EG Ümit, HO Kırkızlar, AC Özdöver, AM Demir
Turkish Journal of Hematology 36 (1), 43, 2019
192019
The incidence of venous thromboembolism and impact on survival in Hodgkin lymphoma
O Kirkizlar, TA Kirkizlar, EG Umit, I Asker, M Baysal, V Bas, SK Gulsaran, ...
Clinical Lymphoma Myeloma and Leukemia 20 (8), 542-547, 2020
162020
Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age
EG Umit, M Baysal, AM Demir
European Journal of Cancer Care 27 (2), e12810, 2018
162018
The utility of CONUT score in diffuse large B cell lymphoma patients
M Baysal, V Bas, U Demirci, SK Gulsaran, E Umit, HO Kirkizlar, AM Demir
Nigerian Journal of Clinical Practice 24 (8), 1194-1199, 2021
142021
CD 11c expression in chronic lymphocytic leukemia revisited, related with complications and survival
EG Umit, M Baysal, Y Durmus, AM Demir
International Journal of Laboratory Hematology 39 (5), 552-556, 2017
132017
Could antinuclear antibody positivity be a factor affecting treatment response in immune thrombocytopenia patients on eltrombopag?
M Baysal, V Baş, E Ümit, HO Kırkızlar, AM Demir
Turkish Journal of Hematology 39 (1), 38, 2022
102022
Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment
V Bas, EG Umit, U Korkmaz, M Baysal, S Karaman Gulsaran, U Demirci, ...
Supportive Care in Cancer 29 (5), 2475-2480, 2021
92021
Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia
M Baysal, E Ümit, HO Kırkızlar, AM Demir
Turkish Journal of Haematology: Official Journal of Turkish Society of …, 2021
92021
Evaluation of Sarcopenia with F‐18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma
EG Umit, U Korkmaz, M Baysal, S Karaman Gulsaran, V Bas, U Demirci, ...
European Journal of Cancer Care 29 (6), e13318, 2020
72020
Drug induced thrombotic microangiopathy with certolizumab pegol
M Baysal, EG Ümit, F Sarıtaş, NS Kodal, AM Demir
Balkan Medical Journal 35 (5), 398-399, 2018
72018
Is JAK2V617F mutation the only factor for thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms?
MS Uyanik, M Baysal, GE Pamuk, M Maden, M Akker, EG Umit, M Demir, ...
Indian Journal of Hematology and Blood Transfusion 32, 262-267, 2016
72016
Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient
N Alkis, M Baysal
SAGE Open Medical Case Reports 10, 2050313X221091392, 2022
62022
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other …
H Cohen, DJ Werring, A Chandratheva, P Mittal, KMJ Devreese, ...
Journal of Thrombosis and Haemostasis 21 (10), 2963-2976, 2023
52023
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review
M Baysal, M Bayrak, AE Eşkazan
Expert Review of Hematology 16 (2), 131-140, 2023
52023
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study
M Baysal, V Gürsoy, FC Hunutlu, B Erkan, U Demirci, V Bas, SK Gulsaran, ...
Annals of hematology 101 (5), 1049-1057, 2022
52022
Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib
SK Gülsaran, M Baysal, U Demirci, V Baş, HO Kirkizlar, E Umit, AM Demir
Journal of Oncology Pharmacy Practice 26 (2), 478-480, 2020
52020
Value of extracellular high mobility group box 1 (HMGB1) in the clinical context of immune thrombocytopenia
EG Umit, M Baysal, V Bas, H Goze, V Asoglu, O Kirkizlar, AM Demir
Journal of Clinical and Experimental Investigations 10 (2), em00724, 2019
52019
系统目前无法执行此操作,请稍后再试。
文章 1–20